Rutan
Showing 1 - 25 of 111
Patients With COVID-19 Trial in Tashkent (The drug "Rutan 0.1"., Basic treatment)
Completed
- Patients With COVID-19
- The drug "Rutan 0.1".
- Basic treatment
-
Tashkent, UzbekistanErkin Musabaev
May 15, 2023
COVID-19 Respiratory Infection Trial in Tashkent (Rutan 25 mg, Control group)
Completed
- COVID-19 Respiratory Infection
- Rutan 25 mg
- Control group
-
Tashkent, UzbekistanTashkent Institute of Virology
May 16, 2023
Tranexamic Acid, Burns, Surgery Trial in Ars-Laquenexy, Lyon, Marseille (Tranexamic Acid, Placebo)
Active, not recruiting
- Tranexamic Acid
- +3 more
- Tranexamic Acid
- Placebo
-
Ars-Laquenexy, France
- +3 more
Feb 8, 2022
Ann Arbor Stage II Non-Hodgkin Lymphoma, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial
Active, not recruiting
- Ann Arbor Stage II Non-Hodgkin Lymphoma
- +2 more
- Cyclophosphamide
- +6 more
-
Mobile, Alabama
- +189 more
Jan 28, 2023
Stroke Trial in Dallas (GWTG Stroke program)
Recruiting
- Stroke
- GWTG Stroke program
-
Dallas, TexasAmerican Heart Association
Jun 4, 2020
Tranexamic Acid, Burn, Major Surgery Trial in Grand Rapids (Tranexamic Acid, Placebo Comparator)
Terminated
- Tranexamic Acid
- +2 more
- Tranexamic Acid
- Placebo Comparator
-
Grand Rapids, MichiganSpectrum Health Hospital
Aug 20, 2021
Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States
Active, not recruiting
- Acute Myeloid Leukemia
- +13 more
- Azacitidine
- Gemtuzumab Ozogamicin
-
Burbank, California
- +176 more
Mar 25, 2022
Lung Cancer Trial in Australia, Canada, United States (lobectomy, segmentectomy or wedge resection)
Active, not recruiting
- Lung Cancer
- lobectomy
- segmentectomy or wedge resection
-
Birmingham, Alabama
- +385 more
Nov 17, 2022
Lymphoma Trial in United States (biological, drug, radiation)
Active, not recruiting
- Lymphoma
- rituximab
- +5 more
-
Anchorage, Alaska
- +258 more
Sep 23, 2022
Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in Canada, United States (Dasatinib, Imatinib Mesylate, Laboratory
Active, not recruiting
- Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- Dasatinib
- +2 more
-
Burbank, California
- +340 more
Jan 28, 2023
Plasma Cell Myeloma Trial in Israel, United States (Laboratory Biomarker Analysis, Lenalidomide, Melphalan)
Active, not recruiting
- Plasma Cell Myeloma
- Laboratory Biomarker Analysis
- +5 more
-
Mobile, Alabama
- +392 more
Jan 25, 2023
Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia Trial in
Active, not recruiting
- Stage I Chronic Lymphocytic Leukemia
- +3 more
- Cyclophosphamide
- +4 more
-
Scottsdale, Arizona
- +363 more
Dec 30, 2022
Diabetic Foot Ulcer Trial in United States (AMNIOEXCEL Plus Amniotic Membrane, A Marketed Comparator, Standard of Care)
Completed
- Diabetic Foot Ulcer
- AMNIOEXCEL Plus Amniotic Membrane
- +2 more
-
Fresno, California
- +6 more
Jul 17, 2020
Heart Failure Trial in Dallas (GWTG Heart Failure program)
Recruiting
- Heart Failure
- GWTG Heart Failure program
-
Dallas, TexasAmerican Heart Association
Jun 26, 2019
Advanced Pancreatic Neuroendocrine Tumor, Locally Advanced Pancreatic Neuroendocrine Tumor, Pancreatic Gastrinoma Trial in
Completed
- Advanced Pancreatic Neuroendocrine Tumor
- +5 more
- Bevacizumab
- +2 more
-
Mobile, Alabama
- +393 more
Aug 3, 2022
Invasive Breast Carcinoma, Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v6 Trial in Puerto Rico, United States
Active, not recruiting
- Invasive Breast Carcinoma
- +3 more
- Bevacizumab
- +4 more
-
Mobile, Alabama
- +525 more
Jan 28, 2023
Melanoma (Skin) Trial in Worldwide (interferon alfa-2b, observation)
Active, not recruiting
- Melanoma (Skin)
- interferon alfa-2b
- observation
-
Birmingham, Alabama
- +532 more
Jun 8, 2022
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma, Fallopian Tube Transitional Cell Carcinoma
Active, not recruiting
- Fallopian Tube Endometrioid Adenocarcinoma
- +29 more
- Bevacizumab
- +4 more
-
Birmingham, Alabama
- +572 more
Jan 28, 2023
Breast Cancer Trial in United States (systemic chemo, axillary lymph node dissection, neoadjuvant therapy)
Active, not recruiting
- Breast Cancer
- systemic chemotherapy
- +5 more
-
Mobile, Alabama
- +323 more
Aug 16, 2021
Colon Mucinous Adenocarcinoma, Colon Signet Ring Cell Adenocarcinoma, Lynch Syndrome Trial in Worldwide (biological, drug,
Active, not recruiting
- Colon Mucinous Adenocarcinoma
- +5 more
- Bevacizumab
- +4 more
-
Anniston, Alabama
- +935 more
Oct 18, 2022
Lung Cancer Trial in United States (bevacizumab, erlotinib HCl)
Completed
- Lung Cancer
- bevacizumab
- erlotinib hydrochloride
-
Antioch, California
- +147 more
Mar 20, 2020
Advanced Adult Hepatocellular Carcinoma, Recurrent Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v7 Trial in
Completed
- Advanced Adult Hepatocellular Carcinoma
- +9 more
- Doxorubicin Hydrochloride
- +3 more
-
Birmingham, Alabama
- +672 more
Aug 3, 2022
Breast Ductal Carcinoma In Situ Trial in Worldwide (other, biological, radiation)
Active, not recruiting
- Breast Ductal Carcinoma In Situ
- Laboratory Biomarker Analysis
- +2 more
-
Anniston, Alabama
- +1267 more
Jan 28, 2023
Lung Cancer Trial in United States (cisplatin, gemcitabine HCl)
Completed
- Lung Cancer
- cisplatin
- gemcitabine hydrochloride
-
Fort Smith, Arkansas
- +146 more
Feb 19, 2020